Temsirolimus for patients with metastatic renal cell carcinoma: outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center

AIM: Temsirolimus has shown efficacy as first-line treatment of patients with metastatic renal cell carcinoma and poor prognostic features. The efficacy of temsirolimus in other clinical settings, such as second-line therapy, is unclear. The aim of this study was to investigate the outcomes of an un...

Descripción completa

Detalles Bibliográficos
Autores principales: Afshar, Mehran, Pascoe, Jennifer, Whitmarsh, Sue, James, Nicholas, Porfiri, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277119/
https://www.ncbi.nlm.nih.gov/pubmed/25552898
http://dx.doi.org/10.2147/DDDT.S73686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277119/
https://www.ncbi.nlm.nih.gov/pubmed/25552898
http://dx.doi.org/10.2147/DDDT.S73686

Ejemplares similares